| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |